Will Oklo Stock Double?
Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…
Sell
30
CTOR Quote, Financials, Valuation and Earnings
Last price:
$1.98
Seasonality move
:
-44.01%
Day range:
$2.82 - $3.20
52-week range:
$0.55 - $49.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.66x
Volume:
596.8K
Avg. volume:
2.3M
1-year change:
-75.28%
Market cap:
$201.8M
Revenue:
--
EPS (TTM):
-$0.33
Earnings Data
Next earnings date for CTOR
Dec 26
2025
Most recent earnings per share
-$0.11
Missed by $0.11
(May 14/2025)
Consensus Estimate
--
(May 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CTOR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/26/2025 | Q3 | -- | -- | -- | -- | -- |
| 08/08/2025 | Q2 | -- | -- | -- | -- | -- |
| 05/14/2025 | Q1 | $5.7M | -- | -$0.11 | -- | -- |
| 02/14/2025 | Q4 | -- | -- | -$0.09 | -- | -- |
| 12/27/2024 | Q3 | -- | -- | -- | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.07 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.07 | -- | -- |
Citius Oncology Earnings Questions
-
How Much did Citius Oncology Generate in Revenue Last Quarter?
Citius Oncology reported -- worth of top line sales in its most recent quarter.
-
Did Citius Oncology Beat Earnings Last Quarter?
Citius Oncology announced earnings per share of -$0.11 which represents a miss of analyst forecast a -- per share.
-
Is Citius Oncology Profitable?
Citius Oncology reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Citius Oncology EPS Next Year?
Citius Oncology's earnings are forecast to grow from -$0.31 per share to -- per share next year representing an increase of --.
-
When is Citius Oncology's Earnings Date?
Citius Oncology's next earnings date is December 26, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why a $5 Stock Is Suddenly a Cash Machine
If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…
Is Roku Stock Undervalued Now?
At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…
Stock Ideas
Buy
69
Is NVDA Stock a Buy?
Market Cap: $4T
P/E Ratio: 56x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 43x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
58
INKT alert for Jul 14
MiNK Therapeutics [INKT] is down 36.03% over the past day.
Buy
51
NEGG alert for Jul 14
Newegg Commerce [NEGG] is down 26.42% over the past day.
Buy
68
ATRO alert for Jul 14
Astronics [ATRO] is down 1.02% over the past day.
